Ewing's sarcoma

Ewing's sarcoma is a malignant neoplasm that predominantly affects bones and soft tissues, mainly in children and adolescents. This tumor belongs to the group of sarcomas, that is, it is part of a broader classification of tumors arising from mesenchymal tissues. Ewing's sarcoma can develop both in the limbs and in other parts of the body, including the pelvis, spine and ribs. This disease mainly affects patients aged 10 to 20 years, with a predominance among males. It is important to note that Ewing's sarcoma has its own special clinical and morphological characteristics, which makes it a separate pathology in oncology.

History of the disease and interesting historical facts

Ewing's sarcoma was first described in 1921 by American pathologist John Ewing, who identified it as a separate clinical and morphological type of tumor. Similar tumors were known earlier, but their classification and understanding of the mechanism of development came only thanks to his research. An interesting fact is that Ewing's sarcoma was long treated as osteosarcoma or myosarcoma before clear differences were established. In 1982, treatment methods for this tumor were developed, which improved the prognosis for patient survival.

Epidemiology

According to statistics, Ewing's sarcoma accounts for about 1% of all malignant tumors found in children and adolescents. Approximately 200-300 new cases of the disease are registered worldwide annually. The disease is more common in whites, while it is much less common among dark-skinned patients. Women are slightly less likely to get the disease than men, with the ratio of cases being approximately 1:1.7. According to statistics, the average age of diagnosis is 15 years, indicating a high incidence rate in adolescence.

Genetic predisposition to this disease

Ewing's sarcoma is associated with chromosomal abnormalities, the most significant of which is a translocation between chromosomes 11 and 22, leading to the formation of the fusion gene EWS-FLI1. This gene encodes a protein that plays a key role in tumor development. Studies also indicate the involvement of other genes, such as EWSR1 and ETS, but EWS-FLI1 is considered the main pathogenetic marker. The presence of these genetic mutations creates a predisposition to the development of Ewing's sarcoma, although it is not the only risk factor.

Risk factors for the development of this disease

It has been proven that certain factors may contribute to the development of Ewing's sarcoma:

• Age: The risk is greatest in adolescents and young adults.
• Gender: Men are more susceptible to the disease than women.
• Genetic predisposition: presence of family history of malignant tumors.
• Certain genetic syndromes: Li-Fraumeni syndrome and neurofibromatosis.
• Residence in certain geographic areas associated with high rates of disease.

Certain chemicals and radiation in the environment may also increase the risk of developing the disease.

Diagnosis of this disease

Diagnosis of Ewing's sarcoma includes several stages:

• Main symptoms: the appearance of a tumor, pain in the area of the tumor, swelling, difficulty with movement.
• Laboratory tests: tests for tumor markers, biochemical blood tests.
• Radiological examinations: X-ray, MRI and CT to determine the size and location of the tumor.
• Other types of diagnostics: biopsy for morphological confirmation of the diagnosis.
• Differential diagnosis: exclusion of other sarcomas, osteomyelitis and benign formations.

Treatment

Treatment of Ewing sarcoma is a complex process and involves several approaches:

• General treatment: a combination approach using chemotherapy, radiotherapy and surgery.
• Pharmacological treatment: high-intensity chemotherapeutic regimens such as VINCRISTINE, DACTINOMYCIN and DOXORUBICIN.
• Surgical treatment: radical resection of the tumor, which is often a necessary stage of treatment.
• Other types of treatment: clinical trials of new drugs and therapies.

List of medications used to treat this disease

Among the main drugs used in the treatment of Ewing's sarcoma, the following can be distinguished:

• Doxorubicin
• Vincristine
• Ifosfamide
• Etoposide
• Actinomycin D

Disease monitoring

Monitoring of Ewing sarcoma includes regular specialist examinations and the use of radiological methods. The prognosis depends on the stage of the disease at the time of diagnosis, usually the 5-year survival rate is 60-70% for localized forms and decreases to 15-30% if there is metastasis. Complications can include relapse, metastasis, and long-term effects of chemotherapy.

Age-related features of the disease

The course of Ewing's sarcoma in different age groups can vary significantly. In children under 10 years of age, the disease can manifest itself aggressively, while adolescents are more likely to encounter localized forms. Older patients may experience complications in treatment and increased risks of side effects from therapy.

Questions and Answers

• What is the main cause of Ewing sarcoma? The main cause of Ewing sarcoma is associated with genetic mutations, including the formation of the EWS-FLI1 fusion gene.
• What is the prognosis for Ewing sarcoma? The prognosis depends on the stage of the disease; with early detection, survival can reach 70% in a 5-year period.
• What diagnostic methods are the most effective? The most effective diagnostic methods include biopsy, MRI and CT scan to evaluate the tumor that has developed.
• Are there any preventative measures to reduce the risk of disease? There are currently no specific preventive measures, but families should be monitored for genetic history and known risks should be avoided.
• How is Ewing sarcoma treated in children? Treatment includes chemotherapy, surgery and, in rare cases, radiation therapy.

Advice from Dr. Oleg Korzhikov

Dr. Oleg Korzhikov recommends that parents closely monitor their children's health, especially during adolescence, and do not delay a visit to a specialist if there is any suspicion of a tumor. "Knowledge of your family history, early diagnosis, and competent treatment can be decisive in the fight against Ewing's sarcoma," he emphasizes. Advice on timely visits to a doctor when suspicious symptoms appear and regular preventive examinations can significantly improve the prognosis of the disease.